XCL1 and melanoma: This is reminiscent of a recent study in mice showing that NK cells in implanted melanomas, breast, and colon cancers played a critical role in recruiting cDC1 via the production of CCL5 and XCL1, with important antitumor effects (Böttcher et al., 2018).